Eli Lilly and Co (NYSE:LLY) revealed that it will sell Baqsimi, its nasal treatment for severe hypoglycemia in people with diabetes, to Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) for around $1 billio
Higher demand for its key drugs is likely to have offset generic competition for several drugs and may have boosted Lilly's (LLY) first-quarter sales.
Shares of Eli Lilly & Co. LLY gained 0.5% in premarket trading Monday, after the drugmaker announced an agreement to sell its hypoglycemia treatment for people with diabetes Baqsimi to Amphastar Pharm

3 Stocks With Huge Catalysts on the Way

06:18am, Saturday, 22'nd Apr 2023
Axsome Therapeutics has several major milestones around the corner. CRISPR Therapeutics could soon win approvals for its first product.
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Eli Lilly and Apple are cash-rich businesses that can afford to pay dividends and invest in the future. Mounjaro is a weight-loss treatment that could bring in tens of billions in revenue for Eli Lill

Is Eli Lilly Stock a Buy Now?

08:45am, Thursday, 20'th Apr 2023
Eli Lilly has faced a series of issues over the past few months. But the drugmaker's pipeline still looks promising.
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Sanofi (SNY) or Eli Lilly (LLY). But which of these two companies is the best option for those lookin
The topic of weight loss drugs has been making recent headlines. The positive phase 1 clinical trial for Viking Therapeutics Inc. (NASDAQ: VKTX) GLP-1 treatment VK2735 caused its shares to rally more

Get In Now. 3 Stocks That Are Set to Soar.

08:30am, Sunday, 16'th Apr 2023
As the market shows some stability, investors are looking for stocks to buy for the long term. Some great stocks remain undervalued and look like bargains at their current prices, but for how long?
The FDA rejects Eli Lilly's (LLY) regulatory filing seeking approval for mirikizumab to treat ulcerative colitis indication, citing issues related to the drug's proposed manufacturing.
INDIANAPOLIS , April 13, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2023 financial results on Thursday, April 27, 2023. Lilly will also conduct a conference
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
With recession fears on the rise, look into some sectors that can shield from market volatility.
Looking for a go-anywhere stock fund that isn't trapped in a style box and can buy stocks of all sizes and styles? Well, Justin White's T.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE